Gossamer Bio

(NASDAQ) GOSS

Current Price$0.35

Market Cap$78.86M

Since IPO (2019)-98%

5 Year-96%

1 Year-68%

1 Month+1%

Gossamer Bio Financials at a Glance

Market Cap

$78.86M

Revenue (TTM)

$48.47M

Net Income (TTM)

$170.37M

EPS (TTM)

$-0.75

P/E Ratio

-0.45

Dividend

$0.00

Beta (Volatility)

1.96 (High)

Dividend

$0.00

Beta (Volatility)

1.96 (High)

Price

$0.35

Volume

66,086

Open

$0.34

Price

$0.35

Volume

66,086

Open

$0.34

Previous Close

$0.35

Daily Range

$0.33 - $0.36

52-Week Range

$0.32 - $3.87

Dividend

$0.00

Beta (Volatility)

1.96 (High)

Price

$0.35

Volume

66,086

Open

$0.34

Previous Close

$0.35

Daily Range

$0.33 - $0.36

52-Week Range

$0.32 - $3.87

GOSS News

Businessman looking down at red line descending

Are There Good Investments Among 2019's Biotech IPOs?

David HaenOct 2, 2019

GOSS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gossamer Bio

Industry

Biotechnology

Sector

Health Care

Employees

162

CEO

Faheem Hasnain

Website

www.gossamerbio.com

Headquarters

San Diego, CA 92121, US

GOSS Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-783%

Return on Capital

-2%

Return on Assets

-99%

Earnings Yield

-2.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$78.86M

Shares Outstanding

234.70M

Volume

66.09K

Avg. Volume

16.31M

Financials (TTM)

Gross Profit

$47.47M

Operating Income

$163.25M

EBITDA

$162.25M

Operating Cash Flow

$171.27M

Capital Expenditure

$79.00K

Free Cash Flow

$171.34M

Cash & ST Invst.

$136.93M

Total Debt

$201.97M

Gossamer Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$13.80M

+47.1%

Gross Profit

$13.57M

+44.7%

Gross Margin

98.35%

N/A

Market Cap

$78.86M

N/A

Market Cap/Employee

$547.62K

N/A

Employees

144

N/A

Net Income

$47.24M

-43.0%

EBITDA

$45.81M

-44.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$65.04M

-171.0%

Accounts Receivable

$12.53M

+134.7%

Inventory

$0.00

N/A

Long Term Debt

$201.97M

+0.0%

Short Term Debt

$938.00K

-2.4%

Return on Assets

-98.91%

N/A

Return on Invested Capital

-1.57%

N/A

Free Cash Flow

$48.31M

-36.2%

Operating Cash Flow

$48.31M

-36.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RIGLRigel Pharmaceuticals, Inc.

RIGLRigel Pharmaceuticals, Inc.$26.67-5.06%

RGNXREGENXBIO Inc.

RGNXREGENXBIO Inc.$10.22+10.85%

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$10.42+7.31%

PRTAProthena Corporation plc

PRTAProthena Corporation plc$11.18-0.09%

LXRXLexicon Pharmaceuticals, Inc.

LXRXLexicon Pharmaceuticals, Inc.$1.60-3.03%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

VTYXVentyx Biosciences, Inc.

VTYXVentyx Biosciences, Inc.$14.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.19-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

CPNGCoupang

CPNGCoupang$17.89-0.14%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

Questions About GOSS

What is the current price of Gossamer Bio?

Gossamer Bio is trading at $0.35 per share.

What is the 52-week range for Gossamer Bio?

Over the past 52 weeks, Gossamer Bio has traded between $0.32 and $3.87.

How much debt does Gossamer Bio have?

As of the most recent reporting period, Gossamer Bio reported total debt of $202.91M.

How much cash does Gossamer Bio have on hand?

Gossamer Bio reported $37.73M in cash and cash equivalents in its most recent financial results.

What is Gossamer Bio’s dividend yield?

Gossamer Bio does not currently have a dividend yield.

Gossamer Bio

Gossamer Bio Financials at a Glance

GOSS News

Why Gossamer Bio Stock Is Tumbling Today

Why Gossamer Bio Stock Is Crashing Today

Is Gossamer Bio a Buy?

Why Gossamer Bio Stock Is Swinging Wildly Today

Are There Good Investments Among 2019's Biotech IPOs?

GOSS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Gossamer Bio

GOSS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Gossamer Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GOSS

What is the current price of Gossamer Bio?

What is the 52-week range for Gossamer Bio?

How much debt does Gossamer Bio have?

How much cash does Gossamer Bio have on hand?

What is Gossamer Bio’s dividend yield?

Premium Investing Services